-Issues related to FDA review of active ingredients in over-the-counter products
-Issues related to Ingredient Regulations (no bill)
-Issues Related to Product Safety and Quality Assurance (No Bill)
-Issues related to Generally Recognized As Safe designation (no bill)
-Issues related to counterfeit products/illicit trade/cargo theft -Section 338 Canada Tariffs -Issues Related to the Review of the US-Mexico-Canada Trade Agreement (No Bill) -Section 122 Balance of Payment Tariffs -Section 301 Excess Capacity/Forced Labor Investigations -U.S.-China Board of Trade
-H.R.8870 - BUILD America 250 Act (gross vehicle weight limit pilot program provision)
-Issues related to Toxic Substances Control Act Reform (no bill) -Safer Choice Program Authorization Act S4664
-HR 6832 PACK Act (Packaging and Claims Knowledge Act) -HR 7502 RMAA (Recycled Materials Attribution Act) -Issues related to sustainability/recycling (no bill) -H.R. 2269/S. 1092 - Wastewater Infrastructure Pollution Prevention and Environmental Safety (WIPPES) Act
-Implementation of H.R. 1 - One Big Beautiful Bill Act (Corporate/International Provisions) -OECD Digital Tax Project (Global Minimum Tax Implementation) -Strengthening Benefit Plans Act (S. 2003) -Ongoing Negotiations of US Bilateral Tax Treaties -H.R. 1219 Oral Health Products Inclusion Act
-Issues related to FAA Taxiway designations for local airports